If your doctor could tell you that you'll get breast cancer, would you want to know?

Counsyl, a Silicon Valley company that screens prospective parents for their risk of passing on rare inherited diseases, has expanded its genetic testing service to assess your inherited risks for breast, ovarian, prostate, and pancreatic cancers. The expanded testing, which arrived on the heels of $28 million in new funding raised from Goldman Sachs and others, comes in the midst of a national discussion over the proper role of genetic testing in preventative medicine. Last fall the Food and Drug Administration ordered 23AndMe to stop selling its DNA test kit out of concern that the company had marketed its products without necessary regulatory approvals. Its tests require physician approval, and they’ve been designed to help patients make decisions about reproduction and mastectomies that could preempt breast cancer.

via Tech News Headlines - Yahoo News http://ift.tt/1joeT5g